Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Bulks Up Its Generics Business

This article was originally published in The Pink Sheet Daily

Executive Summary

Deal with the Indian pharma company Aurobindo highlights the giant’s interest in expanding its product mix.

You may also be interested in...



Pfizer Ramps Up Its Biosimilars Business

Strategy includes launching 10 monoclonal antibodies by 2016 at the earliest

Pfizer Ramps Up Its Biosimilars Business

Strategy includes launching 10 monoclonal antibodies by 2016 at the earliest

Pfizer Leaps Into Japanese Generics Foray; Aims For 100 Generic Products By 2011

Pfizer's Established Products Business Unit, a branch in charge of invigorating off-patent drugs and leading generic drug activities, will establish commercial operations in Japan starting Dec. 1

Related Content

Topics

UsernamePublicRestriction

Register

PS069199

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel